Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4,370.00 GBX | +1.72% | +5.14% | +2.96% |
01-15 | UK Stocks Cheers Inflation Surprise, Upbeat Trading Updates | MT |
01-15 | UK consumer price data brings "welcome respite" | AN |
Fiscal Period: September | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 7.26 | 8.48 | 8.26 | 8.25 | 8.27 | |||||
Return on Total Capital | 9.33 | 10.47 | 10.25 | 10.17 | 10.12 | |||||
Return On Equity % | 11.64 | 13.01 | 15.78 | 15.07 | 14.47 | |||||
Return on Common Equity | 11.62 | 13.13 | 15.81 | 15.11 | 14.5 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 36.11 | 36.63 | 36.98 | 45.67 | 46.45 | |||||
SG&A Margin | 23.2 | 22.16 | 21.56 | 17.46 | 17.2 | |||||
EBITDA Margin % | 16.77 | 17.55 | 20.7 | 21.88 | 21.83 | |||||
EBITA Margin % | 15.88 | 16.38 | 19.68 | 20.81 | 20.76 | |||||
EBIT Margin % | 12.91 | 14.47 | 15.41 | 16.32 | 16.3 | |||||
Income From Continuing Operations Margin % | 9.25 | 8.85 | 9.42 | 9.86 | 9.53 | |||||
Net Income Margin % | 9.16 | 8.86 | 9.35 | 9.81 | 9.48 | |||||
Net Avail. For Common Margin % | 9.16 | 8.86 | 9.35 | 9.81 | 9.48 | |||||
Normalized Net Income Margin | 7.65 | 8.45 | 8.65 | 8.69 | 8.71 | |||||
Levered Free Cash Flow Margin | 13.39 | 6.62 | 9.51 | 10.86 | 9.48 | |||||
Unlevered Free Cash Flow Margin | 13.68 | 7.21 | 10.31 | 12.28 | 10.8 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.9 | 0.94 | 0.86 | 0.81 | 0.81 | |||||
Fixed Assets Turnover | 12.49 | 11.26 | 10.53 | 9.89 | 10.49 | |||||
Receivables Turnover (Average Receivables) | 7.04 | 8.75 | 7.76 | 7.34 | 7.4 | |||||
Inventory Turnover (Average Inventory) | 3.39 | 4.15 | 3.57 | 2.9 | 2.85 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 3.49 | 1.66 | 1.63 | 2.06 | 2.17 | |||||
Quick Ratio | 2.54 | 0.78 | 0.77 | 1.04 | 0.94 | |||||
Operating Cash Flow to Current Liabilities | 0.77 | 0.66 | 0.47 | 0.8 | 0.73 | |||||
Days Sales Outstanding (Average Receivables) | 52 | 41.7 | 47.03 | 49.7 | 49.47 | |||||
Days Outstanding Inventory (Average Inventory) | 108.1 | 87.92 | 102.13 | 125.97 | 128.53 | |||||
Average Days Payable Outstanding | 52.97 | 40.52 | 43.57 | 52.17 | 70.33 | |||||
Cash Conversion Cycle (Average Days) | 107.13 | 89.1 | 105.59 | 123.5 | 107.68 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 6.35 | 47.04 | 65.8 | 44.05 | 61.71 | |||||
Total Debt / Total Capital | 5.97 | 31.99 | 39.69 | 30.58 | 38.16 | |||||
LT Debt/Equity | 4.99 | 41.92 | 59.34 | 42.35 | 60.24 | |||||
Long-Term Debt / Total Capital | 4.7 | 28.51 | 35.79 | 29.4 | 37.25 | |||||
Total Liabilities / Total Assets | 23.6 | 44.99 | 51.54 | 43.25 | 49.51 | |||||
EBIT / Interest Expense | 27.8 | 15.19 | 11.92 | 7.23 | 7.72 | |||||
EBITDA / Interest Expense | 39.04 | 19.87 | 16.98 | 10.24 | 10.9 | |||||
(EBITDA - Capex) / Interest Expense | 35.68 | 19.21 | 15.89 | 9.44 | 10.24 | |||||
Total Debt / EBITDA | 0.35 | 1.71 | 1.98 | 1.43 | 1.76 | |||||
Net Debt / EBITDA | -1.77 | 1.54 | 1.79 | 1.21 | 1.58 | |||||
Total Debt / (EBITDA - Capex) | 0.38 | 1.77 | 2.11 | 1.55 | 1.87 | |||||
Net Debt / (EBITDA - Capex) | -1.94 | 1.59 | 1.91 | 1.31 | 1.68 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -1.16 | 46.25 | 28.63 | 18.51 | 13.59 | |||||
Gross Profit, 1 Yr. Growth % | -1.32 | 48.35 | 29.85 | 21.42 | 15.52 | |||||
EBITDA, 1 Yr. Growth % | -10.51 | 49.89 | 33.65 | 26.01 | 13.33 | |||||
EBITA, 1 Yr. Growth % | -10.94 | 47.6 | 34.94 | 26.16 | 13.29 | |||||
EBIT, 1 Yr. Growth % | -17.16 | 59.52 | 37.05 | 26.55 | 13.48 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -20.19 | 39.96 | 36.87 | 24 | 9.89 | |||||
Net Income, 1 Yr. Growth % |